TY  - JOUR

T1  - Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.

JO  - BMJ

UR  - https://eprints.whiterose.ac.uk/id/eprint/200117

PY  - 2023/05/30

AU  - Nakafero G

AU  - Grainge MJ

AU  - Williams HC

AU  - Card T

AU  - Taal MW

AU  - Aithal GP

AU  - Fox CP

AU  - Mallen CD

AU  - van der Windt DA

AU  - Stevenson MD

AU  - Riley RD et al

ED  - 

DO  - DOI: 10.1136/bmj-2022-074678

PB  - BMJ

VL  - 381

Y2  - 2025/11/05

ER  -